Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
D-α-Hydroxyglutaric acid (D-2-HG) is an α-hydroxy acid.1 It decreases the oxygen consumption rate (OCR) and ratio of ATP to ADP in U87 glioma cells when used at a concentration of 800 µM. D-2-HG (100 µM) increases the levels of thiobarbituric acid reactive substances (TBARS) in isolated rat cerebral cortex homogenates.2 Urinary levels of D-2-HG are increased in D-2-hydroxyglutaric aciduria, a neurometabolic disease characterized by epilepsy, muscle hypotonia, and delays in psychomotor development.3,4 D-2-HG is structurally similar to α-ketoglutarate, the product of wild-type isocitrate dehydrogenases, and competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone lysine demethylases and DNA hydroxylases.5,6,7
WARNING This product is not for human or veterinary use.
1. 2-
2. D-
3. IDH2 Mutations in Patients with D-
4. Mutations in the D-
5. IDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives. Clin. Cancer Res. 18(20), 5562-5571 (2012).
6. Oncometabolite 2-
7. The oncometabolite 2-